{"AllianceGenome": "11257", "HGNC": "11257", "MIM": "182125", "_id": "6697", "_version": 1, "accession": {"genomic": ["AB017547.1", "AB017548.1", "AC012366.10", "AC092630.3", "CH471053.2", "CP068276.2", "NC_000002.12", "NC_060926.1", "NG_008234.1"], "protein": ["AAA60314.1", "AAD14079.1", "AAH17310.1", "AAY14743.1", "AAY15035.1", "BAA34534.1", "BAA34535.1", "BAD96662.1", "BAF84545.1", "EAW99757.1", "EAW99758.1", "NP_003115.1", "P35270.1"], "rna": ["AK222942.1", "AK291856.1", "BC017310.2", "BF434649.1", "M76231.1", "NM_003124.5", "S71376.1"], "translation": [{"protein": "AAH17310.1", "rna": "BC017310.2"}, {"protein": "BAD96662.1", "rna": "AK222942.1"}, {"protein": "NP_003115.1", "rna": "NM_003124.5"}, {"protein": "AAA60314.1", "rna": "M76231.1"}, {"protein": "AAD14079.1", "rna": "S71376.1"}, {"protein": "BAF84545.1", "rna": "AK291856.1"}]}, "alias": "SDR38C1", "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2021-06-04T22:18:15.205Z", "disease_label": "dopa-responsive dystonia due to sepiapterin reductase deficiency", "gcep": "Aminoacidopathy Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0012994", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_1c9f2ff6-39f1-4abc-9fdf-de4c0e23120d-2021-06-04T221815.205Z", "sop": "SOP7"}}, "ec": "1.1.1.153", "ensembl": {"gene": "ENSG00000116096", "protein": ["ENSP00000234454", "ENSP00000519026", "ENSP00000519027"], "transcript": ["ENST00000234454", "ENST00000498749", "ENST00000713723"], "translation": [{"protein": "ENSP00000519026", "rna": "ENST00000498749"}, {"protein": "ENSP00000519027", "rna": "ENST00000713723"}, {"protein": "ENSP00000234454", "rna": "ENST00000234454"}], "type_of_gene": "protein_coding"}, "entrezgene": "6697", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 4.97184807336, "exp_mis": 79.7640918262, "exp_syn": 43.0103138469, "lof_z": -0.0125065893968583, "mis_z": 0.918105839335888, "mu_lof": 4.72065221285e-07, "mu_mis": 1.12603219679e-05, "mu_syn": 6.15954319714e-06, "n_lof": 5.0, "n_mis": 63.0, "n_syn": 30.0, "p_li": 0.000439257239321401, "p_null": 0.580033762750254, "p_rec": 0.419526980010425, "syn_z": 1.22984618745577}, "bp": 786, "cds_end": 73118666, "cds_start": 73114561, "n_exons": 3, "nonpsych": {"exp_lof": 4.45192172364, "exp_mis": 72.1461216787, "exp_syn": 38.8803979538, "lof_z": 0.210349473947985, "mis_z": 0.958789699089787, "mu_lof": 4.72065221285e-07, "mu_mis": 1.12603219679e-05, "mu_syn": 6.15954319714e-06, "n_lof": 4.0, "n_mis": 56.0, "n_syn": 27.0, "p_li": 0.00276951711185089, "p_null": 0.458000354560484, "p_rec": 0.539230128327665, "syn_z": 1.19957993250536}, "nontcga": {"exp_lof": 4.56941381825, "exp_mis": 73.3782833062, "exp_syn": 39.5647978597, "lof_z": 0.262771944373823, "mis_z": 1.12704519635004, "mu_lof": 4.72065221285e-07, "mu_mis": 1.12603219679e-05, "mu_syn": 6.15954319714e-06, "n_lof": 4.0, "n_mis": 54.0, "n_syn": 28.0, "p_li": 0.00278456775747494, "p_null": 0.426692439025733, "p_rec": 0.570522993216793, "syn_z": 1.16414200423319}, "transcript": "ENST00000234454.5"}, "exons": [{"cdsend": 72891537, "cdsstart": 72887432, "chr": "2", "position": [[72887407, 72887736], [72888313, 72888604], [72891346, 72892158]], "strand": 1, "transcript": "NM_003124", "txend": 72892158, "txstart": 72887407}], "exons_hg19": [{"cdsend": 73118666, "cdsstart": 73114561, "chr": "2", "position": [[73114536, 73114865], [73115442, 73115733], [73118475, 73119287]], "strand": 1, "transcript": "NM_003124", "txend": 73119287, "txstart": 73114536}], "generif": [{"pubmed": 15241655, "text": "haploinsufficiency of SPR can be a rare cause of dopa-responsive dystonia"}, {"pubmed": 16443856, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16443856, "text": "Potentially modulates the onset of or risk for Parkinson's disease."}, {"pubmed": 17270157, "text": "Although association of SPR to Parkinson's disease (PD) is not strong enough to support that this is the PARK3 gene, this study further implicates a role for SPR in idiopathic PD."}, {"pubmed": 18502672, "text": "Genomic DNA revealed the same homozygous point mutation introducing a premature stop codon in the SPR gene in 2 siblings."}, {"pubmed": 19415819, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19415819, "text": "This reduced transcription rate for SPR promoter haplotypes 2 and 3 may impact on antidepressant response and susceptibility to bipolar disorder."}, {"pubmed": 19491146, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19674121, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20038947, "text": "Observational study, meta-analysis, and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20337188, "text": "We examine the sleep, sleep-wake rhythms, CSF neurotransmitters, and melatonin profile in a patient with sepiapterin reductase deficiency."}, {"pubmed": 20877624, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21782285, "text": "this large association study for the SPR gene revealed no association for Parkinson disease worldwide."}, {"pubmed": 22018912, "text": "SRD can manifest as early-onset parkinsonism, widening the spectrum of the disease phenotype and adding to the genetic heterogeneity of the disease"}, {"pubmed": 23640889, "text": "SPR-mediated reduction of sepiapterin and redox cycling occur by distinct mechanisms"}, {"pubmed": 24096079, "text": "Authors identified SPR as a novel regulator of ODC enzyme activity and, based on clinical evidence, present a model in which SPR drives ODC-mediated malignant progression in neuroblastoma."}, {"pubmed": 24588500, "text": "new homozygous mutation in the SPR gene was found in two sisters with dopa-responsive dystonia"}, {"pubmed": 26093909, "text": "We earlier presented evidence for a physical interaction between ODC and SPR and we showed that RNAi-mediated knockdown of SPR expression significantly reduced native ODC enzyme activity and impeded Neuroblastoma cell proliferation."}, {"pubmed": 27613114, "text": "The allele frequencies for the SPR c.596-2A > G (0.7%) polymorphism is not a major cause of Parkinson's disease in the Maltese."}, {"pubmed": 33903016, "text": "Molecular and metabolic bases of tetrahydrobiopterin (BH4) deficiencies."}], "genomic_pos": {"chr": "2", "end": 72892158, "ensemblgene": "ENSG00000116096", "start": 72887382, "strand": 1}, "genomic_pos_hg19": {"chr": "2", "end": 73119287, "start": 73114489, "strand": 1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0006729", "qualifier": "involved_in", "term": "tetrahydrobiopterin biosynthetic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006729", "pubmed": 1883349, "qualifier": "involved_in", "term": "tetrahydrobiopterin biosynthetic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006809", "pubmed": 15197144, "qualifier": "involved_in", "term": "nitric oxide biosynthetic process"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0070062", "pubmed": [19056867, 23533145], "qualifier": "located_in", "term": "extracellular exosome"}], "MF": [{"category": "MF", "evidence": "TAS", "id": "GO:0004033", "pubmed": 1883349, "qualifier": "enables", "term": "aldo-keto reductase (NADPH) activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0004757", "qualifier": "enables", "term": "sepiapterin reductase (NADP+) activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0004757", "qualifier": "enables", "term": "sepiapterin reductase (NADP+) activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0050661", "pubmed": 1883349, "qualifier": "enables", "term": "NADP binding"}]}, "homologene": {"genes": [[7165, 1277951], [7227, 31781], [7955, 554136], [7955, 795445], [8364, 100145068], [9031, 425255], [9544, 705317], [9598, 470403], [9606, 6697], [9615, 483118], [9913, 533836], [10090, 20751], [10116, 29270]], "id": 37735}, "interpro": [{"desc": "Short-chain dehydrogenase/reductase SDR", "id": "IPR002347", "short_desc": "SDR_fam"}, {"desc": "Sepiapterin reductase", "id": "IPR006393", "short_desc": "Sepiapterin_red"}, {"desc": "NAD(P)-binding domain superfamily", "id": "IPR036291", "short_desc": "NAD(P)-bd_dom_sf"}], "ipi": "IPI00017469", "map_location": "2p13.2", "name": "sepiapterin reductase", "other_names": ["Sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)", "sepiapterin reductase", "sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)", "short chain dehydrogenase/reductase family 38C, member 1"], "pantherdb": {"HGNC": "11257", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "103078", "ortholog_type": "LDO", "panther_family": "PTHR44085", "taxid": 10090, "uniprot_kb": "Q64105"}, {"RGD": "3753", "ortholog_type": "LDO", "panther_family": "PTHR44085", "taxid": 10116, "uniprot_kb": "P18297"}, {"Ensembl": "ENSGALG00000000067", "ortholog_type": "LDO", "panther_family": "PTHR44085", "taxid": 9031, "uniprot_kb": "E1C4L3"}, {"ZFIN": "ZDB-GENE-050522-412", "ortholog_type": "LDO", "panther_family": "PTHR44085", "taxid": 7955, "uniprot_kb": "F1QWX4"}, {"ZFIN": "ZDB-GENE-070719-1", "ortholog_type": "O", "panther_family": "PTHR44085", "taxid": 7955, "uniprot_kb": "B3DJY2"}, {"FlyBase": "FBgn0030041", "ortholog_type": "O", "panther_family": "PTHR44085", "taxid": 7227, "uniprot_kb": "Q9W3F1"}, {"FlyBase": "FBgn0014032", "ortholog_type": "LDO", "panther_family": "PTHR44085", "taxid": 7227, "uniprot_kb": "O76752"}, {"dictyBase": "DDB_G0290009", "ortholog_type": "LDO", "panther_family": "PTHR44085", "taxid": 352472, "uniprot_kb": "Q54GP3"}], "uniprot_kb": "P35270"}, "pathway": {"humancyc": {"id": "PWY-5663", "name": "tetrahydrobiopterin <i>de novo</i> biosynthesis"}, "kegg": {"id": "hsa00790", "name": "Folate biosynthesis - Homo sapiens (human)"}, "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-1474151", "name": "Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation"}, {"id": "R-HSA-196854", "name": "Metabolism of vitamins and cofactors"}, {"id": "R-HSA-202131", "name": "Metabolism of nitric oxide: NOS3 activation and regulation"}, {"id": "R-HSA-203615", "name": "eNOS activation"}, {"id": "R-HSA-8978934", "name": "Metabolism of cofactors"}], "smpdb": [{"id": "SMP00005", "name": "Pterine Biosynthesis"}, {"id": "SMP00486", "name": "Dopa-responsive dystonia"}, {"id": "SMP00487", "name": "Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency"}, {"id": "SMP00488", "name": "Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)"}, {"id": "SMP00489", "name": "Hyperphenylalaninemia due to dhpr-deficiency"}, {"id": "SMP00490", "name": "Segawa syndrome"}, {"id": "SMP00491", "name": "Sepiapterin reductase deficiency"}]}, "pdb": ["1Z6Z", "4HWK", "4J7U", "4J7X", "4XWY", "4Z3K", "6I6C", "6I6F", "6I6P", "6I6T", "6I6V", "6I79", "6USN", "7DSF"], "pfam": "PF00106", "pharmgkb": "PA36087", "pharos": {"target_id": 8245, "tdl": "Tchem"}, "pir": "JQ1176", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF256671", "relationship": "is"}, {"id": "GNF256672", "relationship": "is"}, {"id": "GNF256673", "relationship": "is"}, {"id": "GNF256674", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF047990", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF089709", "relationship": "is"}, {"id": "GNF089710", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF051705", "relationship": "is"}, {"id": "GNF061233", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF068121", "relationship": "is"}, {"id": "GNF068122", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF013933", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF286578", "relationship": "is"}, "NIBRI_hs-Secretome_pDEST": {"id": "GNF334771", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF094178", "relationship": "is"}, {"id": "GNF133835", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000002.12", "NC_060926.1", "NG_008234.1"], "protein": "NP_003115.1", "rna": "NM_003124.5", "translation": {"protein": "NP_003115.1", "rna": "NM_003124.5"}}, "reporter": {"HG-U133_Plus_2": "203458_at", "HG-U95Av2": "32108_at", "HTA-2_0": "TC02000435.hg.1", "HuEx-1_0": "2488584", "HuGene-1_1": "8042696", "HuGene-2_1": "16881434"}, "summary": "This gene encodes an aldo-keto reductase that catalyzes the NADPH-dependent reduction of pteridine derivatives and is important in the biosynthesis of tetrahydrobiopterin (BH4). Mutations in this gene result in DOPA-responsive dystonia due to sepiaterin reductase deficiency. A pseudogene has been identified on chromosome 1. [provided by RefSeq, Jul 2008].", "symbol": "SPR", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1420371"}, "unigene": "Hs.301540", "uniprot": {"Swiss-Prot": "P35270"}, "wikipedia": {"url_stub": "Sepiapterin reductase"}}